diebold nixdorf inc. - DBD

DBD

Close Chg Chg %
42.50 0.25 0.59%

Closed Market

42.75

+0.25 (0.59%)

Volume: 68.43K

Last Updated:

Jan 3, 2025, 3:59 PM EDT

Company Overview: diebold nixdorf inc. - DBD

DBD Key Data

Open

$42.50

Day Range

42.49 - 43.08

52 Week Range

27.66 - 51.57

Market Cap

$1.60B

Shares Outstanding

37.58M

Public Float

37.02M

Beta

1.97

Rev. Per Employee

N/A

P/E Ratio

0.74

EPS

$57.16

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

122.48K

 

DBD Performance

1 Week
 
-0.44%
 
1 Month
 
-8.83%
 
3 Months
 
-3.41%
 
1 Year
 
48.23%
 
5 Years
 
N/A
 

DBD Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About diebold nixdorf inc. - DBD

Diebold Nixdorf, Inc. engages in the provision of integrated software-led services, self-service delivery and security systems to financial, retail, commercial, and government markets. It offers financial self-services such as self-service support and maintenance, value-added services, self-service software, and self-service products, and security solutions including physical and electronic security. It operates through the following segments: Eurasia Banking, Americas Banking, and Retail. The company was founded in 1859 and is headquartered North Canton, OH.

DBD At a Glance

Diebold Nixdorf, Inc.
350 Orchard Avenue NE
North Canton, Ohio 44720-2556
Phone 1-330-490-4000 Revenue 3.76B
Industry Electronic Equipment/Instruments Net Income 1.38B
Sector Electronic Technology 2023 Sales Growth 8.666%
Fiscal Year-end 12 / 2024 Employees 21,000
View SEC Filings

DBD Valuation

P/E Current 0.744
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 0.79
Price to Sales Ratio 0.289
Price to Book Ratio 1.022
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 6.476
Enterprise Value to Sales 0.495
Total Debt to Enterprise Value 0.733

DBD Efficiency

Revenue/Employee 179,071.429
Income Per Employee 65,528.571
Receivables Turnover 5.21
Total Asset Turnover 1.041

DBD Liquidity

Current Ratio 1.516
Quick Ratio 1.101
Cash Ratio 0.426

DBD Profitability

Gross Margin 23.30
Operating Margin 4.021
Pretax Margin 38.513
Net Margin 36.594
Return on Assets 38.082
Return on Equity N/A
Return on Total Capital 56.665
Return on Invested Capital 74.947

DBD Capital Structure

Total Debt to Total Equity 128.285
Total Debt to Total Capital 56.195
Total Debt to Total Assets 32.79
Long-Term Debt to Equity 124.187
Long-Term Debt to Total Capital 54.40
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Diebold Nixdorf Inc. - DBD

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
3.90B 3.91B 3.46B 3.76B
Sales Growth
-11.51% +0.11% -11.38% +8.67%
Cost of Goods Sold (COGS) incl D&A
2.85B 2.85B 2.68B 2.88B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
180.40M 149.10M 126.00M 136.30M
Depreciation
73.70M 46.40M 29.80M 34.50M
Amortization of Intangibles
106.70M 102.70M 96.20M 101.80M
COGS Growth
-14.61% +0.05% -5.77% +7.54%
Gross Income
1.06B 1.06B 778.50M 876.20M
Gross Income Growth
-1.89% +0.27% -26.48% +12.55%
Gross Profit Margin
+27.07% +27.12% +22.50% +23.30%
2020 2021 2022 2023 5-year trend
SG&A Expense
932.70M 889.10M 758.90M 725.00M
Research & Development
127.00M 126.60M 111.70M 95.10M
Other SG&A
805.70M 762.50M 647.20M 629.90M
SGA Growth
+10.85% -4.67% -14.64% -4.47%
Other Operating Expense
- - - -
-
Unusual Expense
133.10M 42.60M 272.90M (1.53B)
EBIT after Unusual Expense
(9.70M) 127.20M (253.30M) 1.68B
Non Operating Income/Expense
13.60M 6.90M 8.90M 13.20M
Non-Operating Interest Income
6.80M 6.10M 10.00M 13.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
273.40M 184.80M 194.20M 246.20M
Interest Expense Growth
+39.42% -32.41% +5.09% +26.78%
Gross Interest Expense
273.40M 184.80M 194.20M 246.20M
Interest Capitalized
- - - -
-
Pretax Income
(269.50M) (50.70M) (438.60M) 1.45B
Pretax Income Growth
-17.74% +81.19% -765.09% +430.21%
Pretax Margin
-6.91% -1.30% -12.67% +38.51%
Income Tax
(1.00M) 27.70M 149.20M 75.70M
Income Tax - Current - Domestic
3.90M 2.30M 12.50M (5.60M)
Income Tax - Current - Foreign
14.60M 38.20M 43.30M 47.40M
Income Tax - Deferred - Domestic
3.10M (1.40M) 71.00M 3.60M
Income Tax - Deferred - Foreign
(22.60M) (11.40M) 22.40M 30.30M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(267.80M) (78.10M) (585.60M) 1.38B
Minority Interest Expense
1.30M 700.00K (4.20M) 500.00K
Net Income
(269.10M) (78.80M) (581.40M) 1.38B
Net Income Growth
+21.15% +70.72% -637.82% +336.69%
Net Margin Growth
-6.90% -2.02% -16.80% +36.59%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(269.10M) (78.80M) (581.40M) 1.38B
Preferred Dividends
- - - -
-
Net Income Available to Common
(269.10M) (78.80M) (581.40M) 1.38B
EPS (Basic)
-3.4678 -1.0064 -7.3595 36.6309
EPS (Basic) Growth
+22.07% +70.98% -631.27% +597.74%
Basic Shares Outstanding
77.60M 78.30M 79.00M 37.57M
EPS (Diluted)
-3.4678 -1.0064 -7.3595 36.6309
EPS (Diluted) Growth
+22.07% +70.98% -631.27% +597.74%
Diluted Shares Outstanding
77.60M 78.30M 79.00M 37.57M
EBITDA
303.80M 318.90M 145.60M 287.50M
EBITDA Growth
-34.11% +4.97% -54.34% +97.46%
EBITDA Margin
+7.79% +8.17% +4.21% +7.65%

Snapshot

Average Recommendation BUY Average Target Price 57.50
Number of Ratings 2 Current Quarters Estimate 0.87
FY Report Date 03 / 2025 Current Year's Estimate 4.935
Last Quarter’s Earnings 1.055 Median PE on CY Estimate N/A
Year Ago Earnings 3.72 Next Fiscal Year Estimate 5.675
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate 0.87 1.21 4.94 5.68
High Estimates 1.04 1.21 5.37 6.40
Low Estimate 0.70 1.20 4.50 4.95
Coefficient of Variance 27.63 0.59 12.47 18.07

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Diebold Nixdorf Inc. - DBD

Date Name Shares Transaction Value
May 22, 2024 Thomas S. Timko EVP, CFO 28,036 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 22, 2024 Thomas S. Timko EVP, CFO 46,819 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 22, 2024 Thomas S. Timko EVP, CFO 93,916 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Frank Tobias Baur EVP of Operational Excellence 23,112 Open market or private purchase of non-derivative security Non-derivative transaction at $39.46 per share 911,999.52
May 7, 2024 Octavio Marquez President and CEO; Director 134,439 Open market or private purchase of non-derivative security Non-derivative transaction at $38.89 per share 5,228,332.71
May 7, 2024 Octavio Marquez President and CEO; Director 134,674 Open market or private purchase of non-derivative security Non-derivative transaction at $38.92 per share 5,241,512.08
Apr 8, 2024 Capital Research & Management Co. (World Investors) 341,898 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.44 per share 11,433,069.12
Apr 8, 2024 Capital Research & Management Co. (World Investors) 341,814 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.16 per share 11,334,552.24
Mar 6, 2024 Jonathan Myers EVP - Global Banking 28,320 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Elizabeth C. Radigan EVP - Chief People Officer 18,144 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 James A. Barna EVP, CFO 17,714 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2024 Ilhami Cantadurucu EVP - Global Retail 18,132 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 22, 2024 Marjorie L. Bowen Director 42,290 Open market or private purchase of non-derivative security Non-derivative transaction at $33.98 per share 1,437,014.20

Diebold Nixdorf Inc. in the News